The Food and Drug Administration late last night announced amendments of Pfizer and Moderna’s COVID-19 vaccine emergency use authorizations to allow for the use of a third, additional dose for certain immunocompromised individuals. FDA specifically mentioned boosters for solid organ transplant recipients or those who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise. The agency instructs that the third dose be administered at least 28 days following the two-dose regimen of the same vaccine to individuals ages 18 or older for Moderna and ages 12 or older for Pfizer. The Centers for Disease Control and Prevention’s vaccine advisory committee today voted unanimously to recommend a third dose of the Pfizer and Moderna Covid-19 vaccines for those immunocompromised patients, pending final approval from CDC Director Rochelle Walensky, M.D.

Following FDA’s announcement, the Centers for Medicare & Medicaid Services confirmed  that such boosters are to be made available at no cost to immunocompromised Medicare beneficiaries. CMS says that the Medicare program will continue to pay providers $40 to administer this additional dose, the same amount it pays for other doses of the COVID-19 vaccine.
 

Related News Articles

Perspective
For nearly 20 grueling months, hospitals and health systems — and their steadfast front-line caregivers — have risen to the incredible challenges caused by…
Headline
The AHA has received a $1 million grant from the Centers for Disease Control and Prevention to continue for one year its efforts to encourage COVID-19…
Headline
A pair of peer-reviewed studies published in the New England Journal of Medicine are affirming the safety and effectiveness of Pfizer’s COVID-19 vaccine, first…
Headline
The Food and Drug Administration yesterday released an updated enforcement policy related to face masks, barrier face coverings, face shields,…
Headline
The AHA today released a new issue of the COVID-19 Snapshot, underscoring the persisting challenges facing hospitals and health systems during the ongoing…
Headline
The AHA Sept. 17 at 10 a.m. ET is hosting a webinar with HCA Healthcare leaders Edmund Jackson, M.D., and Jeffrey Guy, M.D., who will share oxygen conservation…